Differences in cellular and humoral responses were also reported in recent publications on vaccine responses after two doses of BNT162b2 in nursing home residents (31) as well as in rheumatoid arthritis patients treated with anti-CD20 antibodies who did not mount antibody production but significant IFN-γ levels (32). The gene discussed is IFNG; the disease is rheumatoid arthritis.